{"transactions":[{"id":2265929,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":127193,"kind":"person","name":"Glanzman Robert","position":1,"cik":"0001835428","reported_name":"Glanzman Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-18T08:34:58.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":4717,"price":2.03,"value":9575.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards.  The sale occurred automatically to satisfy the tax withholding obligation to be funded by a \"sell to cover\" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman."}],"balance_after":10564,"source":{"system":"sec-edgar","filing":"0001562180-22-004174","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835428/000156218022004174/primarydocument.xml","form_type":"4"}},{"id":2392111,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":127193,"kind":"person","name":"Glanzman Robert","position":1,"cik":"0001835428","reported_name":"Glanzman Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-02-16T09:02:05.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2022 as an option for 140,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest  with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested."}],"balance_after":140000,"derivative":{"exercise_price":3.04,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001562180-22-001501","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835428/000156218022001501/primarydocument.xml","form_type":"4"}},{"id":2524709,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":127193,"kind":"person","name":"Glanzman Robert","position":1,"cik":"0001835428","reported_name":"Glanzman Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-11-04T18:57:08.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 4, 2021 as an option for 100,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest  with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested"}],"balance_after":100000,"derivative":{"exercise_price":4.74,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-21-006854","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835428/000156218021006854/primarydocument.xml","form_type":"4"}},{"id":2648026,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":127193,"kind":"person","name":"Glanzman Robert","position":1,"cik":"0001835428","reported_name":"Glanzman Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-01T09:20:27.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":15281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan.  The award fully vests on January 15, 2022."}],"balance_after":15281,"source":{"system":"sec-edgar","filing":"0001562180-21-004607","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835428/000156218021004607/primarydocument.xml","form_type":"4"}},{"id":2734678,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":127193,"kind":"person","name":"Glanzman Robert","position":1,"cik":"0001835428","reported_name":"Glanzman Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2021-04-30T17:16:31.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested"}],"balance_after":95000,"derivative":{"exercise_price":9,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001562180-21-003058","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835428/000156218021003058/primarydocument.xml","form_type":"4"}}]}